Pharmaceutical Stocks: Undervalued and Underrated
ByAinvest
Friday, Oct 3, 2025 4:22 pm ET1min read
CRWV--
CoreWeave (NASDAQ: CRWV), a GPU cloud provider, secured $36.6 billion in combined deals with OpenAI and Meta Platforms. This includes a $6.5 billion expansion of its OpenAI contract and a $14.2 billion compute deal with Meta extending through 2031 [1]. These agreements highlight the limited GPU availability and CoreWeave's credibility as an alternative to hyperscalers like Amazon, Microsoft, and Alphabet. CoreWeave's focus on high-performance AI infrastructure positions it as a leading contender in the market.
Nebius (NASDAQ: NBIS), an infrastructure dark horse, stunned the AI world with a $17.4 billion agreement with Microsoft, with the potential to expand to $19.4 billion. This deal transformed Nebius from a little-known player into a direct competitor for large cloud contracts. Nebius claims to deliver GPU compute more efficiently, with pricing 20% to 25% below traditional providers, leveraging optimized data center design and power efficiency [1]. The terms of the Microsoft deal alone give Nebius a rare valuation bridge to growth peers, though execution risk remains a significant challenge.
SoundHound AI (NASDAQ: SOUN) is bringing conversational interfaces into the mainstream. The company reported $42.7 million in revenue for Q2 2025, a 217% increase from the prior year. SoundHound's technology is embedded in millions of vehicles and used by brands like Chipotle and White Castle for automated drive-through ordering. Despite a GAAP net loss of $74.7 million in Q2, the company's market capitalization exceeds $6 billion, indicating investor confidence in its growth potential [1].
October is a key month for AI stocks, with Q3 earnings reports starting and IT budgets locking in for 2026. These three AI stocks stand out due to their strategic partnerships, growth potential, and innovative offerings. However, investors should consider the substantial obstacles and risks associated with these companies, such as heavy capital demands and execution risk.
META--
MSFT--
The pharmaceutical stocks are expected to outperform the general stock market in 2025 due to conservative valuations and promising pipelines. This prediction is based on the assumption that the industry's valuations are only beginning to be appreciated, indicating potential growth in the future.
As we enter the third quarter of 2025, artificial intelligence (AI) continues to shift from headlines to hard dollars, with enterprises increasingly adopting real deployments and investing in specialized infrastructure. Three AI stocks have emerged as key players in this market, showcasing significant growth and strategic partnerships.CoreWeave (NASDAQ: CRWV), a GPU cloud provider, secured $36.6 billion in combined deals with OpenAI and Meta Platforms. This includes a $6.5 billion expansion of its OpenAI contract and a $14.2 billion compute deal with Meta extending through 2031 [1]. These agreements highlight the limited GPU availability and CoreWeave's credibility as an alternative to hyperscalers like Amazon, Microsoft, and Alphabet. CoreWeave's focus on high-performance AI infrastructure positions it as a leading contender in the market.
Nebius (NASDAQ: NBIS), an infrastructure dark horse, stunned the AI world with a $17.4 billion agreement with Microsoft, with the potential to expand to $19.4 billion. This deal transformed Nebius from a little-known player into a direct competitor for large cloud contracts. Nebius claims to deliver GPU compute more efficiently, with pricing 20% to 25% below traditional providers, leveraging optimized data center design and power efficiency [1]. The terms of the Microsoft deal alone give Nebius a rare valuation bridge to growth peers, though execution risk remains a significant challenge.
SoundHound AI (NASDAQ: SOUN) is bringing conversational interfaces into the mainstream. The company reported $42.7 million in revenue for Q2 2025, a 217% increase from the prior year. SoundHound's technology is embedded in millions of vehicles and used by brands like Chipotle and White Castle for automated drive-through ordering. Despite a GAAP net loss of $74.7 million in Q2, the company's market capitalization exceeds $6 billion, indicating investor confidence in its growth potential [1].
October is a key month for AI stocks, with Q3 earnings reports starting and IT budgets locking in for 2026. These three AI stocks stand out due to their strategic partnerships, growth potential, and innovative offerings. However, investors should consider the substantial obstacles and risks associated with these companies, such as heavy capital demands and execution risk.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet